Trademark Overview
On Wednesday, November 5, 2025, a trademark application was filed for ULMEGZI with the United States Patent and Trademark Office. The USPTO has given the ULMEGZI trademark a serial number of 99480966. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Saturday, March 28, 2026. This trademark is owned by Celgene Corporation. The ULMEGZI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Pharmaceutical preparations for the treatment and prevention of Antivirals;; Pharmaceutical preparations for the treatment and prevention of Antibodies for medical purposes;; Pharmaceutical preparations for the treatment and prevention of Anticoagulants;; Pharmaceutical preparations for the treatment and prevention of Radiopharmaceutical preparations for the treatment of cancer and solid tumors;; Pharmaceutical preparations for the treatment and prevention of Diagnostic radiopharmaceutical preparations;; Pharmaceutical preparations for the treatment and pre...
